2 companies get import ban, fines for selling unqualified drugs, materials

TN News

Email Print

The Drug Administration of Vietnam said on Thursday it has imposed a two-year ban on medicine imports of two foreign companies that were found to sell unqualified medicines and pharmaceutical materials with unclear origins.
Hong Kong-based Austin Pharma Specialties and China-based CSPC Innovation Pharmaceutical were ordered to submit US$30,625 and $29,750, respectively, that they had earned from the illegal sales.
They also had to pay VND160 million ($7,300) each in fines, according to the agency under the Ministry of Health.
The materials in question were used to produce omeprazole and pantoprazole, both "proton pump inhibitors" (PPIs), which are commonly used to treat acid reflux and ulcers of stomach.

More Health News